BKHAU · Black Hawk Acquisition Corp - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - | - | - | - |
| SG&A | $24.2K | - | $311.3K | $217.6K | $78.8K | - | $54.9K | $335.3K | $10.0K |
| Total Operating Expenses | - | - | - | - | - | - | - | - | $30.7K |
| D&A | - | - | - | - | - | - | - | - | - |
| Operating Income | ($54.2K) | - | ($341.3K) | ($247.6K) | ($30.7K) | - | ($84.9K) | ($359.2K) | - |
| Interest Expense | $19.4K | - | - | - | - | - | - | - | - |
| Income Tax | - | - | - | - | - | - | - | - | - |
| Net Income | $139.8K | - | $154.4K | $520.5K | $658.4K | - | $883.8K | $310.9K | ($30.7K) |
| EPS - Basic | - | - | - | - | - | - | - | - | - |
| EPS - Diluted | - | - | - | - | - | - | - | - | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Receivable | - | - | - | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - | - | - | - |
| Accounts Payable | - | - | - | - | - | - | - | - | - |
| Current Assets | $181.4K | $50.8K | $44.5K | $139.5K | $205.3K | $314.1K | $392.5K | $455.0K | $91.8K |
| Total Assets | $24.82M | $23.88M | $23.34M | $73.50M | $72.80M | $72.14M | $71.37M | $70.47M | $226.9K |
| Current Liabilities | $2.29M | $1.48M | $946.2K | $251.0K | $69.7K | $71.0K | $50.5K | $31.3K | $251.5K |
| Long-term Debt | - | - | - | - | - | - | - | - | - |
| Total Liabilities | $4.70M | $3.90M | $3.36M | $2.67M | $2.48M | $2.49M | $2.47M | $2.45M | - |
| Stockholders' Equity | ($4.52M) | ($3.85M) | ($3.32M) | ($2.53M) | ($2.28M) | ($2.17M) | ($2.07M) | ($1.99M) | ($24.6K) |
| Retained Earnings | ($4.52M) | ($3.85M) | ($3.32M) | ($2.53M) | ($2.28M) | ($2.17M) | ($2.07M) | ($1.99M) | ($18.9K) |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ($109.5K) | - | - | - | ($163.3K) | - | - | - | ($37.6K) |
| Investing Cash Flow | ($600.0K) | - | - | - | - | - | - | - | - |
| Financing Cash Flow | $848.4K | - | - | - | - | - | - | - | ($28.1K) |
| CapEx | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - | - | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 |
|---|---|---|---|---|---|---|---|---|---|
| Profitability | |||||||||
| Gross margin | - | - | - | - | - | - | - | - | - |
| Operating margin | - | - | - | - | - | - | - | - | - |
| EBITDA margin | - | - | - | - | - | - | - | - | - |
| Net margin | - | - | - | - | - | - | - | - | - |
| Free cash flow margin | - | - | - | - | - | - | - | - | - |
| FCF / Net income | - | - | - | - | - | - | - | - | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | - | - | - | - | - | - | - | - | - |
| Effective tax rate | - | - | - | - | - | - | - | - | - |
| Return on assets | 0.6% | - | 0.7% | 0.7% | 0.9% | - | 1.2% | 0.4% | -13.5% |
| Return on equity | -3.1% | - | -4.7% | -20.6% | -28.9% | - | -42.6% | -15.6% | 125.0% |
| Return on invested capital | - | - | - | - | - | - | - | - | - |
| Liquidity | |||||||||
| Current ratio | 0.08 | 0.03 | 0.05 | 0.56 | 2.94 | 4.42 | 7.77 | 14.56 | 0.37 |
| Quick ratio | 0.08 | 0.03 | 0.05 | 0.56 | 2.94 | 4.42 | 7.77 | 14.56 | 0.37 |
| Cash ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Leverage | |||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - |
| Interest coverage | -2.8x | - | - | - | - | - | - | - | - |
| Equity multiplier | -5.49 | -6.21 | -7.04 | -29.09 | -31.94 | -33.22 | -34.43 | -35.39 | -9.24 |
| Liabilities / Assets | 0.19 | 0.16 | 0.14 | 0.04 | 0.03 | 0.03 | 0.03 | 0.03 | - |
| Efficiency | |||||||||
| Asset turnover | - | - | - | - | - | - | - | - | - |
| Inventory turnover | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - | - | - | - | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - |
| Valuation | |||||||||
| P / E | - | - | - | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - |
| Growth | |||||||||
| Revenue growth (YoY) | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (3y) | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | -76.5% | - | -301.9% | 31.1% | - | - | - | - | - |
| Net income growth (YoY) | -78.8% | - | -82.5% | 67.4% | - | - | - | - | - |
| EPS growth (YoY) | - | - | - | - | - | - | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | -98.3% | -77.1% | -60.0% | -26.9% | -9183.4% | - | - | - | - |
Peer comparison
Same SIC group: Biological Products, (No Diagnostic Substances)
Comparing Black Hawk Acquisition Corp against the 5 most active filers in the same SIC group.